Cilostazol: Difference between revisions
(Creation of page) |
(No difference)
|
Revision as of 04:13, 26 July 2018
Administration
- Type: Tab
- Dosage Forms: 50 mg, 100 mg
- Routes of Administration: Oral
- Common Trade Names: Pletal
Adult Dosing
Intermittent claudication
- 100 mg PO bid
Pediatric Dosing
Safety/efficacy not established in pediatric patients
Special Populations
Pregnancy Rating
- Caution advised during pregnancy
- No risk of fetal harm, teratogenicity, or death
- Increased risk of maternal bleeding during delivery
Lactation risk
- Caution advised while breastfeeding
Renal Dosing
- Adult: No adjustment
- Pediatric: Unavailable
Hepatic Dosing
- Adult: No adjustment
- Pediatric: Unavailable
Contraindications
- Allergy to class/drug
- CHF
- Hemostatic disorders
- Active bleeding
Adverse Reactions
Serious
- Bleeding
- Angina, MI
- Tachyarrhythmia
- Thrombocytopenia
- Leukopenia, Agranulocytosis
- Anaphylaxis
- Stevens-Johnson Syndrome
Common
- Headache
- Diarrhea, Abnormal stools, abdominal pain
- Palpitations, dizziness, tachycardia
- Peripheral edema
- Dyspepsia
Pharmacology
- Half-life: 11-13 hours; active metabolites
- Metabolism: Liver; CYP450: 2C19, 3A4
- Excretion: Urine 74%, feces 20%
Mechanism of Action
- Inhibits phosphodiesterase type 3, reducing platelet aggregation
- Suppresses cAMP degradation, producing vasodilation
